WATERTOWN, Mass.--(BUSINESS WIRE)--Tetraphase Pharmaceuticals, a clinical-stage life science company with a groundbreaking synthetic chemistry technology platform that has the power to deliver solutions to the global health crisis caused by antibiotic resistance, announced today that it has appointed Patrick Horn, M.D., Ph.D., as the company’s first Chief Medical Officer (CMO).
